Healthcare Royalty Partners Details HCR’s Record For Royalty Receipts and Market Activity in 2021 Year In Review

HealthCare Royalty Partners (“HCR” or the “Firm”) has published its 2021 Year In Review, which is available by clicking the link below.  HCR marked its 15th year in business by generating $800 million in royalty receipts for investors, a record for the Firm. During the year the Firm closed on $770 million in royalty acquisitions, following a record $1 billion of acquisitions in 2020. In the Year In Review, HCR further comments on its position as a key capital provider and partner for biopharmaceutical companies that are developing and marketing innovative and medically necessary products.

Please click here for a more detailed recap of HCR’s activities as well as a summary of the biopharmaceutical financing market in 2021.